Close X
Attorney Spotlight

How did Mike DeAgro's experience co-founding a nonprofit advocacy organization lead to a career in the legal field? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more


Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

Unique Corruption Risks in Emerging Markets

Events

September 13, 2016

Bass, Berry & Sims attorneys John Kelly and Lindsey Fetzer will serve as panelists on a webinar titled, "Unique Corruption Risks in Emerging Markets." This webinar is hosted by AdvaMed Medical Technology Learning Institute and will provide participants an understanding of trends, best practices and corruption risks specific to the life sciences industry in emerging markets.

Topics include:

  • An overview of anti-corruption and bribery enforcement trends, including: recent enforcement actions, Yates Memorandum, DOJ self-reporting Pilot program
  • Best practices in compliance for minimizing risk
  • Analysis of corruption risks including business partners, third parties, clinical trials, regulatory approvals, entertainment and hospitality
  • Overview of challenges faced in emerging markets

The webinar will be held on September 13 from 1:00 - 2:00 p.m. EDT.


Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.